Finance

Lists
Why is 524711 up 2,62%?
Dive Deeper
524711:BOM
Vista Pharmaceuticals Ltd
6,27 INR
+2,62%
(+0,16) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524711...
Open
6,08 INR
High
6,34 INR
Low
5,91 INR
Mkt. cap
385,93 млн
Avg. vol.
11,13 миң
Volume
2,73 миң
52-wk high
10,50 INR
52-wk low
5,32 INR
EPS
-1,90 INR
Shares outstanding
29,15 млн
No. of employees
30
Open
6,08 INR
High
6,34 INR
Low
5,91 INR
Mkt. cap
385,93 млн
Avg. vol.
11,13 миң
Volume
2,73 миң
52-wk high
10,50 INR
52-wk low
5,32 INR
EPS
-1,90 INR
Shares outstanding
29,15 млн
No. of employees
30
News stories
From web sources and news partners
About Vista Pharmaceuticals Ltd
CEO-
Employees30
Founded1991
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 13-фев.
Fiscal period
Q3 2026
- / -
Revenue / Est. (INR)
24,18 млн / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. июн.
Revenue
15,19 млн
14,62 млн
24,18 млн
-
Cost of goods sold
14,98 млн
14,63 млн
22,60 млн
-
Cost of revenue
14,98 млн
14,63 млн
22,60 млн
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,42 млн
5,68 млн
5,90 млн
5,12 млн
Operating expense
13,07 млн
36,36 млн
33,50 млн
10,31 млн
Total operating expenses
28,06 млн
50,99 млн
56,11 млн
10,31 млн
Operating income
-12,87 млн
-36,37 млн
-31,93 млн
-10,31 млн
Other non operating income
-1,10 миң
1,92 млн
897,00 миң
399,00 миң
EBT including unusual items
-14,80 млн
-36,22 млн
-32,80 млн
-13,27 млн
EBT excluding unusual items
-14,80 млн
-36,22 млн
-32,80 млн
-13,27 млн
Income tax expense
-1,90 млн
-10,34 млн
-9,61 млн
-3,41 млн
Effective tax rate
12,82%
28,53%
29,30%
25,71%
Other operating expenses
5,89 млн
28,69 млн
25,74 млн
3,31 млн
Net income
-12,90 млн
-25,88 млн
-23,19 млн
-9,86 млн
Net profit margin
-84,96%
-176,99%
-95,91%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1,93 млн
-1,78 млн
-1,77 млн
-3,36 млн
Net interest expenses
-1,93 млн
-1,78 млн
-1,77 млн
-3,36 млн
Depreciation and amortization charges
1,76 млн
1,99 млн
1,87 млн
1,88 млн
EBITDA
-11,02 млн
-34,49 млн
-30,08 млн
-8,43 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору